Nearly half of ovarian cancer cases are diagnosed in ER, missing critical treatment window, study finds ABC News - Breaking News, Latest News and Videos
Cancer patients are often pressured to end a pregnancy early. They shouldn’t be STAT
Sprinting for a Cure: Annual event funds ovarian cancer research at UCLA Los Angeles Downtown News
Runcie C.W. Chidebe: Last Call for Nominations for the World Ovarian Cancer Coalition Impact Awards 2026 Oncodaily
Six years, one lab: How a summer internship led to a Ph.D. in ovarian cancer research University of Arizona News
Novel ADCs Show Responses in Ovarian and Cervical Cancer at ESMO 2026 Targeted Oncology
Personalized ovarian cancer vaccines spark immunity in phase 1 trial Medical Xpress
Rinatabart Sesutecan for Patients With Platinum-Resistant Ovarian Cancer: First Efficacy and Safety Results From the Phase 2 Cohort of the RAINFOL-01 Study OncLive
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial Nature
ESMO: Lilly touts 79% ADC response rate in competitive ovarian cancer space Fierce Biotech
Un nou fàrmac millora la supervivència en el càncer d’endometri avançat VHIO
The surprising link between ovarian cancer and the fallopian tubes Harvard Health
Eli Lilly (LLY) Reported 100% Disease Control In Phase 1 Ovarian Cancer Data Simply Wall St
Advancing the Conversation on Ovarian Cancer BBJ - Budapest Business Journal
How New Science is Reshaping Ovarian Cancer Treatment and Care American Association for Cancer Research (AACR)
How Far Away Is Earlier Ovarian Cancer Diagnosis? Medscape
UK HealthCare partners with community health providers to expand women’s health services in rural Kentucky UKNow
David OMalley: New FRα-Targeted ADC Shows Promising Activity in Heavily Pretreated Ovarian Cancer Oncodaily
Dr Klobocista on Molecular Testing in Gynecologic Cancers Targeted Oncology
Rinatabart Sesutecan Improves Survival in Platinum-Resistant Ovarian Cancer OncLive
Dr Chase on the Potential Role of B7-H4–Targeted ADCs in Platinum-Resistant Ovarian Cancer OncLive
UMBC research team discovers promising molecular target for ovarian cancer treatment 2026 UMBC - University of Maryland, Baltimore County
How new findings on ovarian cancer origins may help reduce risk PBS
Vaccine Against Ovarian Cancer: Phase 1 Tests Feasibility Denkstrom
Morocco builds local HRD testing for ovarian cancer, cutting reliance on foreign labs Bioengineer.org
INOVIQ (ASX:IIQ) Sonic Healthcare Deal Opens the Door to a US Ovarian Cancer Launch Stocks Down Under
Doctors say family history can indicate inherited breast cancer risk KSLA
Genmab Shares Jump After Positive Cancer Study Results WSJ
ROSELLA Trial: New Ovarian Cancer Treatment Shows Survival Benefit Oncology News Central
Most ‘Ovarian Cancer’ Isn’t. And That Fact Can Save Lives. The New York Times
Rethinking ovarian cancer III: the past decade and future directions Nature
A common cholesterol drug may weaken ovarian cancer defenses Duke School of Medicine
2026 Julie Richardson Procter 5K Ribbon Run Monster Dash Saturday Beaumont Examiner |
Daily Dose: Ovarian cancer's surprising starting point, cycle-synced workouts and simple mood boosters for shorter days WGRZ
Ovarian cancer drug clears major hurdle Yahoo News Canada
Genmab’s acquisition spree starts to pay off with new ovarian and colorectal cancer data European Biotechnology Magazine
Vernon Hills student draws inspiration from mom’s cancer battle to develop early detection tool Daily Herald
Arkansas woman credits breast cancer diagnosis for saving her life KARK
Computational Predictions Fail to Match Measured Activity at Prostate Cancer Risk Variants Bioengineer.org
INOVIQ Signs Validation and License Option Agreement with Sonic Healthcare USA for EXO-OC™ Ovarian Cancer Test Kalkine